Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity-Reference-Cited by-同舟云学术

Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity

Published:2012-10-29 Issue:40 Volume:32 Page:4825-4835
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Arlt A,Sebens S,Krebs S,Geismann C,Grossmann M,Kruse M-L,Schreiber S,Schäfer H

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/onc2012493.pdf

Reference60 articles.

1. Arlt A, Bauer I, Schafmayer C, Tepel J, Muerkoster SS, Brosch M et al. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2). Oncogene 2009; 28: 3983–3996.

2. Akhdar H, Loyer P, Rauch C, Corlu A, Guillouzo A, Morel F . Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells. Eur J Cancer 2009; 45: 2219–2227.

3. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011; 475: 106–109.

4. Hong YB, Kang HJ, Kwon SY, Kim HJ, Kwon KY, Cho CH et al. Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells. Pancreas 2010; 39: 463–472.

5. Jiang T, Chen N, Zhao F, Wang XJ, Kong B, Zheng W et al. High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res 2010; 70: 5486–5496.

Cited by 301 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paricalcitol plus hydroxychloroquine enhances gemcitabine activity and induces mesenchymal to epithelial transition in pancreatic ductal adenocarcinoma: A single cell RNA-seq analysis;Cancer Letters;2025-08

2. The crosstalk between Nrf2 and pyroptosis in diseases;Pathology - Research and Practice;2025-08

3. The role of NRF2 in human cancers: Pre-clinical insights paving the way for clinical trials;Journal of Pharmaceutical Analysis;2025-06

4. Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2–Related Factor 2 Function in Leukemia and Other Cancers;Cells;2025-05-14

5. Thirty years of NRF2: advances and therapeutic challenges;Nature Reviews Drug Discovery;2025-03-04